“Do your best to leave your best footprint to make an impression.”
Dr. Ana Andreazza is a scientist-executive, founder, and board advisor working at the intersection of regenerative medicine, mitochondrial therapeutics, transplantation, and precision health. She is Founder and Scientific Director of the Mitochondrial Innovation Initiative (MITO2i), a strategic University of Toronto initiative, and Professor of Pharmacology & Toxicology and Psychiatry at the University of Toronto, where she also holds the Canada Research Chair in Molecular Pharmacology of Mood Disorders and the Thomas C. Zachos Chair in Mitochondrial Research.
Dr. Andreazza is recognized for building multidisciplinary platforms that connect academia, hospitals, industry, philanthropy, and global collaborators to accelerate innovation and translation. Through MITO2i, she has created an ecosystem focused on moving mitochondrial science from discovery to real-world clinical and commercial impact across brain health, organ preservation, transplantation, and regenerative medicine.
A key differentiator in her profile is her leadership in mitochondrial transplantation, an emerging therapeutic field with applications in tissue repair, inherited mitochondrial disease, organ preservation, and regenerative medicine. She is the Nominated Principal Investigator of MitoRevolution: Mitochondrial Transplantation Transforming Regenerative Medicine—from research to patient care to global impact, a CAD$23,863,672 NFRF-Transformation program designed to advance mitochondrial transplantation toward broad clinical use. Her portfolio also includes related translational programs in lung preservation, ischemia-reperfusion injury, organ-on-chip systems, mitochondrial stabilization, and mitochondrial delivery platforms.
In addition to her executive leadership, Dr. Andreazza brings meaningful governance and advisory experience. She currently serves on the Board of Directors of the Institute for Personalized Therapeutic Nutrition, on the Scientific Steering Committee of BD², and on advisory boards including The Metabolic Group and NOURISH: Nutrition & Mental Health. Her prior board and advisory experience includes the Board of Directors of the International Society for Bipolar Disorders, advisory work with Massachusetts General Hospital, Mayo Clinic, and Janssen Research & Development.
Dr. Andreazza has authored 220 peer-reviewed publications and has received national recognition including Canada Top 40 Under 40, election to the Royal Society of Canada College of New Scholars, and appointment as Senior Fellow of Massey College. She brings boards a rare combination of scientific authority, founder mindset, cross-sector partnership building, non-dilutive funding success, and strategic insight into emerging therapeutics, platform innovation, and health-sector growth.
Board Strengths Strategic innovation leadership | Translational medicine | Regenerative medicine and mitochondrial therapeutics | Cross-sector partnership building | Non-dilutive funding and program scale-up | Scientific and clinical advisory expertise | Governance experience in nonprofit, academic, and health innovation settings.
Character:
Dr. Andreazza demonstrates unwavering integrity and a deep sense of purpose in every aspect of her work. She consistently prioritizes impact-driven initiatives that benefit both scientific advancement and societal well-being. Her commitment to mentorship and empowerment reflects a genuine dedication to uplifting others and fostering inclusive growth.
Knowledge:
With extensive expertise in molecular biology, neuroscience, and pharmacology, Dr. Andreazza possesses a profound understanding of complex scientific systems. Her research contributions have significantly advanced knowledge in mitochondrial function and psychiatric disorders. She continuously expands her intellectual horizons, staying at the forefront of innovation and discovery.
Strategic:
Dr. Andreazza exhibits exceptional strategic vision by aligning scientific research with real-world applications and commercialization opportunities. She has successfully built and led collaborative networks that bridge academia, industry, and healthcare. Her ability to anticipate trends and drive long-term initiatives positions her as a forward-thinking leader.
Communication:
Communicating complex scientific concepts with clarity and precision, making them accessible to diverse audiences. She is an experienced public speaker and thought leader who engages effectively across academic, industry, and public platforms. Her ability to foster collaboration is rooted in her strong interpersonal and communication skills.
https://defygravitycampaign.utoronto.ca/
